135
Participants
Start Date
November 30, 2007
Primary Completion Date
July 31, 2010
Study Completion Date
December 31, 2010
PEP02
"120 mg/m2, IV infusion for 90 minutes on day 1 of each 21 day as a treatment cycle.~Number of Cycles: until progression or unacceptable toxicity develops."
irinotecan
300 mg/m2, IV infusion on day 1 of each 21 day as a treatment cycle. Number of Cycles: until progression or unacceptable toxicity develops.
docetaxel
"75 mg/m2, IV infusion for 60 minutes on day 1 of each 21 day as a treatment cycle.~Number of Cycles: until progression or unacceptable toxicity develops."
Taipei Veterans General Hospital, Taipei
National Cheng Kung University Hospital, Tainan City
Mackay Memorial Hospital, Taipei
Hospital Clínico San Carlos, Madrid
Hospital Universitario Marques de Valdecilla, Santander
Clinical Hospital Mostar, Mostar
Clinical Centre University of Sarajevo, Sarajevo
University Hospital Centre Rijeka, Rijeka
University Hospital Centre Dubrava, Zagreb
University Hospital Centre Zagreb, Zagreb
Samsung Medical Center, Seoul
Asan Medical Center, Seoul
National Cancer Center, Seoul
Hospital Universitario Vall d'Hebron, Barcelona
Hospital General Universitario de Elche, Elche
Chang Gung Memorial Hospital - Chiayi, Chiayi City
Chang Gung Memorial Hospital - LinKou, Linkou District
Addenbrookes Hospital Oncology Center, Cambridge
Guy's & St Thomas' NHS Foundation Trust, London
Kent Oncology Centre, Maidstone Hospital, Maidstone
Southampton University Hospital, Southampton
The Royal Marsden Hospital, Surrey
Lead Sponsor
PharmaEngine
INDUSTRY